查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球螢光透視設備市場
市場調查報告書
商品編碼
1166519

2022-2029 年全球螢光透視設備市場

Global Fluoroscopy Equipment Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內 (2022-2029)，熒光檢查的市場規模預計將以 5.22% 的複合年增長率增長。

透視是一種醫學診斷成像設備，它以與 X 射線電影相同的方式在監視器上顯示 X 射線圖像。 它使用 X 射線實現物體內部的實時動畫，類似於 X 射線照相和計算機斷層掃描。 它可用於心臟和腸道疾病的診斷（病因調查）。 它還用作植入物和注射等治療以及整形外科手術的指南。 您可以查看器官、關節、肌肉和骨骼的內部。

市場動態

介入放射學手術數量的增加、微創手術數量的增加、技術進步的不斷增加以及心血管疾病患病率的上升是全球熒光檢查市場的主要驅動力。是一些關鍵的市場驅動力。

熒光成像設備的最新創新有望推動市場增長。

ControlRad, Inc. 是一家私營醫療技術公司，專注於大幅減少熒光鏡引導手術過程中不必要的輻射暴露，該公司於 2019 年 5 月推出了經 FDA 批准的 ControlRad Trace。 ControlRad Trace 是唯一可以集成到現有移動 C 形臂中以減少任何熒光鏡成像程序中的輻射的技術。 此外，Siemens Healthmeyers 旗下的 Corindus 公司在其 2020 年 5 月號的論文《循環：心血管介入》中報告說，使用 CorPath GRX 系統的機器人 PCI 可以改善手動 PCI，據稱與相比，機器人 PCI 可將患者的輻射暴露減少 20% PCI。 因此，上述因素預計將在預測期內推動市場。

設備的高成本預計會阻礙市場增長。

然而，由於其先進的功能和特點，移動系統也很昂貴，成本超過20萬美元。 先進的移動裝置配備了 20KW 發電機，使其能夠穿透緻密組織。 GE Healthcare 的昂貴產品包括 OEM 9900 Elite 和 GM Imaging 的視覺 RFD，它們配備了大圖像顯示器並能夠進行準確的圖像評估。 除了高昂的設備成本外，打印機和 DICOM 盒等直接成本也會增加總擁有成本。 因此，設備的使用壽命比平均壽命長。 因此，預計上述因素將在預測期內阻礙市場。

COVID-19 影響分析

預計 COVID-19 的爆發將影響 C 型臂市場。 由於 COVID-19 而推遲，通常選擇性圖像引導程序使用 C 臂。 隨著對支持 COVID-19 治療的設備（例如呼吸機）的關注度越來越高，醫院可能在此次大流行期間削減了昂貴的資本支出。 例如，根據英國外科雜誌發表的一項研究，預計 2020 年全球約有 2840 萬例擇期手術將被取消或推遲。 該預測基於 COVID-19 對醫院服務造成的為期 12 週的高峰中斷。 COVID-19 大流行迫使印度取消或推遲了超過 580,000 項計劃中的手術。 但是，為了容納 COVID-19 陽性且需要手術的患者，歐洲泌尿外科協會建議創建配備特殊設備的手術室。 這個房間需要為放射科醫師和醫療保健專業人員提供移動式 C 型臂 X 射線透視系統。 因此，鑑於 COVID-19 病例數量的增加以及對整個地區醫療保健系統的重大影響，預計市場將在預測期內保持目前穩定的增長率軌跡。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 熒光成像的最新創新有望推動市場增長。
    • 約束因素
      • 設備的高成本預計會阻礙市場增長。
    • 機會
    • 影響分析

第五章行業分析

  • 搬運工的五種力量
  • 供應鏈
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 透視設備
  • 固定式 C 型臂
  • 移動全尺寸手臂
  • 移動式迷你 C 型臂

第八章應用

  • 診斷應用
    • 心髒病學
    • 泌尿科/腎臟科
    • 神經血管
    • 其他
  • 手術
    • 整形外科/外傷外科
    • 神經外科
    • 心血管外科
    • 消化外科
    • 其他

第 9 章最終用戶

  • 醫院
  • 診斷中心
  • 門診手術中心
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第12章公司簡介

  • Siemens Healthcare
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • GE Healthcare
  • Philips Healthcare
  • Carestream Health, Inc.
  • Canon Medical Systems
  • Hitachi Medical Systems
  • Shimadzu Corporation
  • Ziehm Imaging GmbH
  • Fujifilm Medical Systems
  • Lepu Medical Technology

第13章 全球螢光透視裝置市場-DataM

簡介目錄
Product Code: DMMI1248

Market Overview

Fluoroscopy Equipment Market size was valued around US$ YY million in 2021 and is expected to reach US$ YY million by 2029, growing at a CAGR of 5.22% during the forecast period (2022-2029).

Fluoroscopy equipment is medical imaging equipment that displays the X-ray image on a monitor, the same as an X-ray movie. It uses X-rays to achieve real-time moving images of the inside of an object, like X-ray radiography and computed tomography. Fluoroscopy can be used to diagnose (determine the cause of) a health problem such as heart or intestinal disease. It is also used to guide treatments such as implants or injections and in orthopedic surgery. It allows the doctor to look inside organs, joints, muscles, and bones.

Market Dynamics

Increasing number of interventional radiology procedures, the rising number of minimally invasive procedures, increased technological advancements, and the growing prevalence of cardiovascular diseases are some of the key market drivers of Global Fluoroscopy Equipment Market.

Latest innovations in fluoroscopic imaging equipment is expected to drive market growth.

ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, launched the FDA-approved ControlRad Trace in May 2019. ControlRad Trace is the only technology that can be integrated into existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure. Moreover, Corindus, a Siemens Healthineers company, announced in the published article "Circulation: Cardiovascular Interventions" in May 2020 states that robotic PCI with the CorPath GRX System reduces patient radiation exposure by 20% compared to manual PCI while increasing fluoroscopy time and contrast utilization. Thus, from the above-mentioned factors, the market is expected to drive in the forecast period.

The high cost of equipment is expected to hamper the market growth.

However, due to their advanced features and functionalities, mobile systems also have a high cost, which is more than USD 200,000. Advanced mobile units have 20KW generators attached, allowing them to penetrate dense tissues. The costliest ones manufactured by GE Healthcare include OEM 9900 Elite and Ziehm Imaging's vision RFD, which include large image displays to enable accurate image evaluation. Apart from the high equipment cost, there are other direct expenses for printers and DICOM boxes which increase the total cost of ownership. Due to this, the usage of the equipment is extended beyond its average life. Thus, from the above factors, the market is expected to be hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is expected to have an effect on the market for C-arms. Image-guided procedures, which are typically elective and were delayed because of COVID-19, use C-arms. Due to their increased focus on ventilators and other COVID-19 treatment-supporting equipment, hospitals may have refrained from investing in expensive capital equipment during the current pandemic. For instance, according to the study published in the British Journal of Surgery, approximately 28.4 million elective surgeries worldwide were anticipated to be canceled or postponed in 2020. This prediction was based on 12 weeks of peak hospital service disruption caused by COVID-19. The COVID-19 pandemic has forced the cancellation or postponement of more than 580,000 scheduled surgeries in India. However, to handle COVID-19-positive patients require surgery, it is recommended by the European Association of Urology that a specially furnished operating room should be created. This room will require a mobile C-arm fluoroscopic X-ray system for radiology and healthcare professionals. Therefore, it is anticipated that the market will maintain its current steady growth rate trajectory during the forecast period, considering the rising cases of COVID-19 and its significant impact on healthcare systems throughout the region.

Segment Analysis

Fluoroscopy devices segment is expected to hold the largest market share in fluoroscopy equipment

The fluoroscopy devices segment accounted for the largest market share in 2021. This is owing to the usage of a wide array of procedures such as image-guided biopsy, angiography, and discography. In addition to this, fluoroscopes are increasingly used in previously unexplored applications such as nondestructive testing of medical devices and quality assurance. The increasing number of recent FDA approvals is expected to accelerate market growth. For instance, on August 4, 2022, Xoran Technologies received FDA 510(k) clearance for TRON, a truly mobile, full-body fluoroscopy, computed tomography (CT) X-ray system. As of February 21, 2019, Agfa Healthcare's DR 800 multipurpose digital radiography (DR) imaging system with tomosynthesis received FDA 510(k) clearance. The DR 800 provides a single solution for advanced clinical applications, multi-slice imaging, fluoroscopy, radiography, and radiography, supporting radiology in value-based care organizations with greater adaptability, functionality, and effectiveness. Thus, from the above-mentioned factors, the market segment is accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global fluoroscopy equipment

North America region accounted for the largest market share in 2021. The increasing prevalence of cardiovascular and orthopedic surgeries, high standards of healthcare infrastructure, the high frequency of diagnostic examination, the rising geriatric population, and the increasing prevalence of chronic diseases in the U.S. are the factors to drive the market in the forecast period. For instance, according to the Centers for Disease Control and Prevention, heart disease is the leading cause of death for both sexes and members of the majority of racial and ethnic groups in the U.S. Cardiovascular disease claims one life in the U.S. every 34 seconds. 1 in 5 deaths in the U.S. in 2020 was caused by heart disease, which affected approximately 697,000 people. Additionally, in 2020, adults under 65 years old accounted for about 2 in 10 deaths from CAD.

Moreover, because of its developed healthcare system, the U.S. has the largest installed base of C-arms globally. Additionally, all C-arms are replaced following the replacement schedule due to the strict regulations in the U.S., according to the healthcare regulatory authorities, which guarantees that the new C-Arm sales in the country are consistent. Thus, from the above factors, the North America region is expected to hold the largest market share in the forecast period.

Global Fluoroscopy Equipment Market- Competitive Landscape

Major key players in the fluoroscopy equipment market include Siemens Healthcare, GE Healthcare, Philips Healthcare, Carestream Health, Inc., Canon Medical Systems, Hitachi Medical Systems, Shimadzu Corporation, Ziehm Imaging GmbH, Fujifilm Medical Systems and Lepu Medical Technology.

For instance, on January 13, 2021, the FDA approved Siemens Cios Flow mobile C-arm in the U.S. It is designed to be a general-purpose C-arm that can be easily used in various cases and is intended for orthopedics, vascular surgery, trauma, spinal surgery, and other fields.

Shimadzu Corporation:

Overview:

Shimadzu Corporation is a Japanese public KK company that manufactures measuring devices, medical equipment, and precision instruments. In order to use advances in science and technology to make society more convenient, secure, and safe, the company operates in four segments: analytical and measuring instruments, medical systems, industrial machinery, and aircraft equipment. Shimadzu Scientific Instruments (SSI) is the Shimadzu Corporation's American subsidiary (Kyoto, Japan). SSI was founded in 1975 as a distribution hub that offered labs and service providers in the Americas analytical solutions. Shimadzu U.S.A. Manufacturing provides HPLC, GC-MS/MS, LC-MS/MS, and other high-tech products to the U.S. market through its ten regional offices strategically positioned across the country. These offices are staffed with experienced technical specialists, service and sales engineers, and a state-of-the-art Customer Training and Education Center.

Product Portfolio:

OPESCOPE ACTENO: It is a mobile C-arm Imaging System whose main applications are X-ray fluoroscopy and radiography during surgery. Lock mechanisms allow individual movement locking, ensuring quick and accurate positioning.

The global fluoroscopy equipment market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Latest innovations in fluoroscopic imaging are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. The high cost of equipment is expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Supply Chain
  • 5.3. Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Fluoroscopy Devices*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Fixed C-Arms
  • 7.4. Mobile Full Size C-Arms
  • 7.5. Mobile Mini C-Arms

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Diagnostic Applications
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth
    • 8.2.3. Cardiology *
    • 8.2.4. Urology and Nephrology
    • 8.2.5. Neurovascular
    • 8.2.6. Others
  • 8.3. Surgical Applications
    • 8.3.1. Orthopedic & Trauma Surgeries
    • 8.3.2. Neurosurgeries
    • 8.3.3. Cardiovascular Surgeries
    • 8.3.4. Gastrointestinal Surgeries
    • 8.3.5. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. Hospitals*
      • 9.2.1.1. Introduction
      • 9.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic Centers
  • 9.4. Ambulatory Surgery Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Siemens Healthcare*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. GE Healthcare
  • 12.3. Philips Healthcare
  • 12.4. Carestream Health, Inc.
  • 12.5. Canon Medical Systems
  • 12.6. Hitachi Medical Systems
  • 12.7. Shimadzu Corporation
  • 12.8. Ziehm Imaging GmbH
  • 12.9. Fujifilm Medical Systems
  • 12.10. Lepu Medical Technology

LIST NOT EXHAUSTIVE

13. Global Fluoroscopy Equipment Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us